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Irradiation of skin with ultraviolet light of sunburn 
range (UVB) leads to a large and rapid induction of the 
polyamine biosynthetic enzyme ornithine decarboxylase 
in the epidermis. Induction of epidermal ornithine de-
carboxylase also occurs following application of the tu-
mor promoting agent 12-0-tetradecanoylphorbol-13 ace-
tate and topical retinoic acid is able to block both this 
ornithine decarboxylase induction and skin tumor pro-
motion. 
In the studies described below, topical application of 
retinoic acid to hairless mouse skin leads to a significant 
inhibition of UVB-induced epidermal ornithine decar-
boxylase activity. The degree of this inhibition was de-
pendent on the dose, timing, and frequency of the appli-
cation of retinoic acid. 
To show significant inhibition of UVB-induced orni-
thine decarboxylase the retinoic acid had to be applied 
within 5 hr ofUVB irradiation. Ifretinoic acid treatment 
was delayed beyond 7 hr following UVB, then no inhi-
bition of UVB-induced ornithine decarboxylase was ob-
served. The quantities ofretinoic acid used (1.7 nmol and 
3.4 n.mol) have been shown effective at inhibiting 12-0-
tetradecanoyl phorbol-13 acetate induced ornithine de-
carboxylase. 
The results show that these concentrations of topical 
retinoic acid applied either before or immediately follow-
ing UVB irradiation reduces the UVB induction of epi-
dermal ornithine decarboxylase. The effect of retinoic 
acid in these regimens on UVB-induced skin carcinogen-
esis is currently under study. 
The activity of the polyamine biosynthetic enzyme ornithine 
decarboxylase (ODC) has been shown to be increased at an 
early stage of cellular proliferation [1-3]. There is also evidence 
that the activities of ODC and its biosynthetic products putres-
cine, spermidine and spermine increase during malignant trans-
formation [1-3]. 
The responses of skin to ultraviolet light (UVL) have been 
studied extensively, and it is well known that exposure of skin 
to ultraviolet light is a major etiologic factor in epidermal 
carcinogenesis [ 4,5]. It has recently been shown that UVL, 
principally of sunburn range (290-320 nm, UVB) produces 
induction of epidermal ODC [6) as does exposure of skin to 
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tumor promoting agents [7-9]. This induction of epidermal 
ODC following UVB preceded the subsequent increase of mac-
romolecular biosynthesis [6]. 
The effects of retinoic acid (RA) on UVB induced ODC are 
of interest for the following reasons. It has been shown that 
topical RA is a potent inhibitor of 12-0-tetradecanoyl phorbol-
13 acetate (TPA)-induced ODC activity in mouse epidermis 
and that treatment of mouse skin with RA prior to subsequent 
exposUTe to TP A significantly inhibited the number of resulting 
papillomas and carcinomas [10]. This has led to speculation 
that modulation of TPA-induced ODC may be useful for study-
ing potential agents capable of inhibit ing experimental carci-
nogenesis. Retinoids have also been shown to inhibit t umors in 
other tissues, including the gastrointestinal tract, v~gina, and 
uterine cervix [ll]. 
The present controversy over whether topical RA enhances 
UVL carcinogenesis remains unresolved. Forbes Urbach, and 
Davies have shown that the application of RA in conjunction 
with solar simulated UVL enhanced UVL-induced carcinogen-
esis in albino hairless mice [12]. Epstein originally showed that 
0.3% RA applied to mice skin in conjunction with hot quartz 
UVL also enhanced UVL carcinogenicity [13]. More recently, 
however, it was found that with lower concentrations of RA 
there was either no enhancement of UVL carcinogenesis or an 
inhibit ion of carcinogenesis [141. 
This study, therefore, investigated t he effects of RA on the 
UVB-induced ODC system with those RA concentrations that 
inhibited TPA-induced ODC activity. 
MATERIALS AND METHODS 
Female albino hail'less mice (Skh/ Hr) were used for experimentation 
at 6 to 8 weeks of age. L-[1- 14 C] orni thine hydrochloride (specific 
activity 59 m Ci/mol) was pw·chased from Amersham Corp., Arlington 
Heights, II. 
The UVB source was a bank of 8 Westinghouse FS 40 sunlamp tubes 
with UV output between 280 and 380 nm with principal emission 
between 290 and 320 nm and peak emission at 313 nm. The mice were 
irradiated in a specially constructed wire cage with individual chambers. 
All mice within each experiment, whether irradiated or control, were 
placed in these chambers for an identical t ime to insure standard ized 
handling. The UVB output was monitored using an IL 700 radiometer 
and a sensor fitted with 313 nm filter calibrated to the in tegral output 
of the lamps from 290-320 nn1. It was connected to a n IL 720 photo-
dosimeter with a feed back circuit to turn off the lamps at the prede-
termined dose (0.09 J /cm2 ) . 
All trans retinoic acid was supplied by Ortho Dermatological Division 
and was dissolved in acetone. 200 ul amounts of the solu tions were 
applied to the hairless mouse skin using a micro pipet. 
Assay of Epidermal Ornithine Decarboxylase Activity 
Enzyme activity was determined by measw·ing the release of '" COl 
from L-(1- 1"1 C) ornithine as previously described [6) with modifications. 
At 6, 24 or 48 hr following single UVB exposure, mice were sacrificed 
by cervical dislocation and back skin removed. The epidermis was 
completely separated from the dermis by brief heat treatment (55°C 
for 30 sec), removed to ice water, placed flat on a piece of glass and the 
epidermis removed by scraping with a # 10 scalpel. The epiderma l 
scrapings were then placed in ice cold buffered saline (1 ml) and 
homogenized using a Brinkman polytron homogenizer at level 6 for 15 
sec. The homogena te was than centrifuged at 30,000 xg for 30 min at 
4 oc and the resulting clear supernate withdrawn and frozen at -70°C. 
At a later time, the samples we1·e thawed and assayed for ODC. Protein 
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content was determined by the Bio-Rad Protein Assay. The ODC assay 
was carried out in 17 mm X 105 mm Pyrex (9820) tubes fi tted with 5 
mm (OD) X 2 mm long sidearm tubes, attached 25 mm below the lip of 
the tube. A # 1 1-hole stopper was slipped over the sidearm to accom-
modate the mou th of a standard scintilation via l. The main tube 
opening was ftl.led with a #14 sleeve stopper to close the system. The 
incubation mixture was prepared as previously described and main-
ta ined on ice. 50 ul NCS (Amersham) was placed in each of the 
scintillation vials before attachment to the reaction tube. When all 
reagents had been added and the tubes capped, the whole rack of tubes 
was placed in a preheated shaking water bath at 37°C and incubated 
for 1 hr at approximately 100 cycles per minute. 
The rack of tubes was then removed from the water bath, cooled in 
ice water for 5 min and 0.5 cc 2 M citric ac id was injected through the 
top and cap past the sidearm into reaction mixture to halt the reaction. 
- The tubes were then returned to the shaking water bath and incubation 
allowed to continued for one more hour. At this t ime, the scintilla tion 
vials were removed from the sidearms and 10 ml OCS (Amersham) was 
added to each vial. The vials were capped and stabilized in the dark for 
60 min at 4 °C before counting a scintillation spectrometer. The activity 
of ODC was expressed in nmol C02/1 hr/ mg protein . 
RESULTS 
The Effects of Pretreatment with RA B efore UVB 
These studies showed that a single application of 1.7 or 3.4 
nmol RA produced inhibition of UVB induced ODC activity six 
hours following UVB (Table I) . Statistical significance was only 
found with 3.4 nm. However, when ODC activity was measured 
24 hr after UVB, no significant inhibition of ODC induction was 
observed with 3.~ nmol RA concentration (Table I). 
The Effects of Post-treatment with RA after UVB 
These studies were performed to exclude any photoprotec-
tant influence of RA and UVB effect. 
Single post-treatment RA after UVB: It was found that a 
single post-UVB application of 3.4 nmol of RA significantly 
inhibited ODC induction measured 6 hr after UVB (Table II). 
However, there was no significant inhibition of ODC induction 
measured 24 hr after UVB. These results, therefore, showed a 
similar pattern to that observed for the pretreatment studies. 
Multiple post-treatment RA after UVB: These results are 
summarized in the Figure. It was found that marked inhibition 
of UVB-induced ODC occurred if RA was applied immediate1y 
following UVB and hourly for 4 hr. There was greatest inhibi-
tion (89%) measured 6 hr after UVB irradiation, compared to 
UVB and acetone treated mice. Of interest is the 70% inhibition 
observed in these studies when the mice were sacrificed 24 hr 
after UVB. The ODC activity was normal again 48 hr after 
UVB, showing that there was true inhibition of UVB induced 
ODC in the RA treated mice ratheJ; than a delayed induction. 
The effects of varying the number of post UVB RA treat-
TABLE I. Effect of sing le application of retinoic acid (RA) I hr prior 
to UVB: Sacrifice 6 hr after UVB 
Group treatment N" ooc• ±SO p ' %Inhibition" 
Acetone + UVB 5 0.52 0.15 
1.7 nmol RA + UVB 5 0.38 0.20 < 0.2 27% 
3.4 nmol RA + UVB 5 0.29 0.11 <0.05 44% 
Effect of S ingle Application of RA 1 hr prior to UVB: Sacrifice 24 hr 
Acetone + UVB 
3.4 nmol RA + UVB 
3.4 nmol RA only 
Acetone only 
after UVB 
6 1.91 
6 1.94 
6 0.09 
6 0.02 
0.30 
0.29 
0.04 
O.Ql 
" N = Number of mice per experimental group. 
ns'' 0 
ns 
ns 
"ODC = Ornithine decarboxylase as nmol C02!hr/ mg protein. 
'" p = Statistical analysis with Students t-test comparing UVB-ace-
tone treated with UVB-RA treated groups. 
d % Inhibition of UVB-RA treated compared to UVB-acetone 
treated. 
• ns = Statistically nonsignificant p > 0.05. 
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TABLE II. Effect of single application of retionic acid (RA) 
immediately following UVB. Sacrifice 6 or 24 hr after UVB (SAC) 
Group treatment N" SAC OOC '' ±SO p '' % lnhibi-tion'' 
UVB + Acetone 5 6 hr 0.53 0.17 
UVB + 3.4 nmol 5 6 hr 0.26 0.13 < 0.025 51% 
RA 
UVB + Acetone 5 24 hr 1.29 0.29 
UVB + 3.4 nmol 5 24 hr 1.05 0.19 ns'' 19% 
RA 
"N = Number of mice per experimenta l group. 
" ODC = Ornithine decarboxylase as nmol C02!hr/ mg protein. 
·· p = Statistical analysis with Students t- test comparing UVB-ace-
tone treated with UVB-RA treated groups. 
d % Inhibit ion of UVB-RA treated compared to UVB-acetone 
treated. 
•· ns = Statistically nonsignificant p > 0.05. 
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Showing the inhibitory influence of multiple applications of 3.4 nmol 
of retinoic acid (RA) on UVB-induced epidermal ornithine decarbox-
ylase activity. Time = Time of sacrifice of mice after UVB irradiation. 
X = p < 0.005. 
ments is shown in Table III. In these studies ODC induction 
was measured 24 hr after UVB. RA applied immediately after 
(0 hr) and 5 hr failed to show any inhibition. RA at 0, 2, and 5 
hr showed 66% inhibition. RA at 0, 1, 2 and 5 hr showed 75% 
inhibition. Delayed single RA treatments following UVB were 
given at 2, 4, or 22 hr resulting in no significant changes of ODC 
activity. 
These results would suggest that between 0 and 5 hr following 
UVB, there are events that control the subsequent induction of 
ODC. RA needs to be available for most of that time to 
influence ODC induction. 
Effects of delaying post UVB RA treatment: Delaying mul-
tiple treatments with RA until 7 hr after UVB and treating at 
8, 9, 10 and 11 hr enhanced rather than inhibited the ODC 
induction measured 24 hr after UVB. These results are shown 
in Table IV. 
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T A BLE III. Effect of vary ing the frequency and times of retinoic acid 
(RA) treatment following UVB ." 
Group treatment N'' ooc·· ±SO p '' % lnhibi· Lion'' 
UVB + acetone 3 1.15 0.30 
UVB + RA at 0, 5 hr 3 1.41 0.30 nsf 0 
UVB + RA 0, 2, 5 hr 3 0.39 0. 13 <0.025 66% 
UVB + RA at 0, 1, 2, 5 lu· 3 0.29 0.10 <0.025 75% 
UVB + RA at 2 hr 4 1.00 0.37 ns 0 
UVB + RA at 4 hr 3 1.04 0.25 ns 0 
UVB + RA at 22 hr 4 1.04 0.22 ns 0 
" Sacrifice 24 hr after UVB. 3.4 nmol of RA used for treatment. (0 hr 
means immediately following UVB). 
" N = Number of mice per ex perimental group. 
,. ODC = Omithine decarboxylase as nmol COz/hr/ mg protein. 
" p = Statistical analysis wi th Students t-test comparing UVB-ace-
tone treated wi th UVB-RA treated groups. 
,. % Inhibi tion of UVB-RA treated compared to UVB-acetone 
treated. 
r ns = Statistically nonsigni ficant p > 0.05. 
TABLE IV. E ffect of delaying application of RA aft er UVB" 
Group treatment N'' ODC'' ±SO p" 
(Times of treatment of RA after 
UVB) 
UVB + Acetone control 7, 8, 9 and 
10 hrs. 
UVB + RA at 7, 8, 9 and 10 hours 
5 
5 
"All mice were sacri ficed 24 hr after UVB. 
3.9 
7. 1 
1
' N = Number of mice per experimental group. 
1.3 
3.7 <0.01 
,. ODC = Ornithine decarboxylase as nmol COt/hr/ mg protein. 
" p = Statistical analysis with Students t- test comparing UVB-ace-
tone treated with UVB-RA treated groups. 
DISCUSSION 
Exposure to U VB radiation results in epidermal cell injury 
a nd death, a n increased mitotic index and an acceleration of 
macromolecular synthesis [15]. It has been recently shown that 
exposure of hairless mice to UVB irradition leads to a m arked 
increase in epidermal ODC activity [6,16]. S ignificant induction 
of epidermal ODC occurred wit hin 2 to 4 lu· after UVB irradia-
t ion and reached a peak a t 24 to 28 hr before declining to 
normal. This increased ODC activity occurred, t herefore, at a 
t ime when epidermal DNA synthesis r ema ined depressed fol-
lowing UVB and before the epidermal prolifera t ive activi ty 
occuned. It has also been previously shown tha t UVB-induced 
ODC activity is depressed by treatmen t wi th cycloheximide, a n 
inhibitor of protein synthesis, and by 5-azacytidine, a n inhibitor 
of nucleic acid synthesis [16]. 
The results reported in this paper demonstrate tha t RA when 
applied on multiple occasions following UVB is a potent inhib-
itor ofUVB-induced mouse epidermal ODC activi ty. The mech-
a nisms of action of retinoic acid on UVB-induced ODC activity 
are not known, bu t r equire the presence of RA during the first 
5 lu· following UVB. Other workers found t hat retinoic acid 
partially inhibited ODC induced by germicidal range UVL (254 
nm, UVC) in vitro. They found that there were 2 peaks of ODC 
induction, one occurring 4 to 6 hr followin g UVC, the second 
after 14 to 17 h1· [17]. It has been suggested that the induction 
of ODC by UVL requires both tra nscriptional and tra nsla tional 
events. The time course of epidermal ODC induction in vivo 
after UVB has been shown to be slightly different wi th an early 
rise which pla teaued between 6 to 8 hr a nd a la ter peak at 
between 24 to 26 hr [16]. 
A single application of RA was able to signifi cantly inhibit 
UVB-induced ODC measm ed 6 ru· after UVB bu t not a fter 24 
hr. However, multiple applications of RA for the first 5 hr 
following UVB significantly inhibited ODC induction at both 
time points. P erhaps as noted, RA is able to block early cellular 
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events that occur after UVB a nd that lead to increased polya-
mine biosynt hesis. This possibility would seem to be in agree-
ment with the findin gs of H addox and Russell, who implicated 
a G1 block a nd inhibition of mR NA synthesis for ODC as a 
vitamin A effect on cell prolife ration [18, 19]. 
The fact t hat there is suppression of UVB induced ODC 
measured at 6 lu· after UVB is interesting as t his is the approx-
ima te t ime course at which t hat RA significantly inhibits TP A 
induction of ODC [10]. The t ime course of ODC induction 
foll owing a single UVB exposure is more prolonged [6) than 
after T PA. 
RA alone in all t hese experiments fa iled to induce epidermal 
ODC. It has been suggested that induction of high levels of 
epidermal ODC is a feature shared by most tumor promoting 
agents [9]. Therefore, the lack of ODC induction exhibi ted here 
by low concentration RA is not consistent with tumor promo-
tion. 
P erhaps m ore releva nt to UVB carcinogenesis are the studies 
recently repor ted by Verma, Conrad, Boutwell [20] on the 
influence of the complete cru·cinogen 7, 12-dimethylbenz (a) 
an thracene (DMBA) on epidermal ODC. They fo und a more 
prolonged t in1e com se of ODC induction following DMBA than 
that observed following T PA and which was actual ly more 
prolonged t ha n that described following UVB [6]. T here was 
no significa nt inhibition of DMB A-induced ODC by a single 
pretreatment wi th RA [20]. T hese workers did not however 
study the effects of mul t iple R A treatm ents following DMBA 
as we have wit h UVB in the studies repor ted h ere. RA pretreat-
men t in the DMBA study [20) also fa il ed to inhibit DMBA 
induced skin tumors in mice. 
The effects of RA acid used in t he regimens that inhibited 
UVB-induced OQC ru·e presently under study for modulation 
of UVB induced carcinogenesis. 
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Announcement 
The National Toxicology Program of the U .S. Departmen.t of Health and Human Services will sponsor 
a conference on the "Photobiologic, Toxicologic, Pharmacologic, and Therapeutic Aspects of Psoralens." 
This conference will be held on March 1-3, 1982, at the National Institutes of Environmental Health 
8ciences, Research Triangle Park, NC, USA. The meeting will cover the basic and clinical aspects of 
psoralen photochemotherapy with special emphasis on psoralen photochemistry, interactions of psoralens 
with DNA, RNA, and proteins, acute and chronic toxicity, mutagenicity, carcinogenicity, structure and 
photosensitivity activity relationship, and clinical responses of various psoralens in relationship to 
photochemotherapy of psoriasis, vitiligo, etc. For further information, please contact Dr. Madhu A. 
Pathak at the Department of Dermatology, Harvard Medical School, Massachusetts General Hospital, 
Boston, MA 02114, U.S.A. (617-726-3996) or Dr. JuneK. Dunnick at the National Toxicology Prog1·am, 
NIEHS, Research Triangle Park, NC, 27709, U.S.A. (919-541-4811) . The meeting is open to all interested 
in psoralens and their usefulness in basic science and medicine. 
